A pilot assessment of xanthine oxidase activity in plasma from patients with hematological malignancies using a highly sensitive assay

Hematol Oncol. 2019 Oct;37(4):527-530. doi: 10.1002/hon.2659. Epub 2019 Aug 27.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / blood*
  • Disease-Free Survival
  • Female
  • Hematologic Neoplasms / blood*
  • Hematologic Neoplasms / mortality*
  • Hematologic Neoplasms / therapy
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Proteins / blood*
  • Pilot Projects
  • Survival Rate
  • Xanthine Oxidase / blood*

Substances

  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Xanthine Oxidase